Published in Medical Verdicts and Law Weekly, April 12th, 2007
This trend article about University of Pittsburgh, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: A report, "Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial," is newly published data in The Journal of Clinical Endocrinology & Metabolism. "Few data are available on the safety and efficacy of once-weekly oral bisphosphonate therapy in breast cancer survivors. Our objective was to determine whether risedronate, 35 mg weekly, is efficacious and safe in preventing bone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly